Sailong Pharmaceutical Group Co., Ltd. (002898.SZ)
CNY 10.94
(0.46%)
CNY 10.94
(0.46%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 35.7 Million | 14.12 Million | 35.46 Million | 174.69 Thousand | -46.51 Million | 3.32 Million |
| Net Income | 9.53 Million | -37.31 Million | -23.34 Million | -67.22 Million | 27.48 Million | 60.9 Million |
| Depreciation & Amortization | 33.13 Million | 34.06 Million | 32.79 Million | 29.29 Million | 20.02 Million | 14.22 Million |
| Deferred income taxes | 12.75 Million | 7.57 Million | 4 Million | 14.55 Million | -17.16 Million | -11.67 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 4.11 Million | 16.39 Million | 28.77 Million | 64.86 Million | -94.53 Million | -74.9 Million |
| Other non-cash items | -11.07 Million | 981.86 Thousand | -2.76 Million | -26.76 Million | 509 Thousand | 3.1 Million |
| Investing Cash Flow | -19.32 Million | -18.35 Million | -22.47 Million | -68.25 Million | -108.62 Million | -132.2 Million |
| Investments in PPE | -30.57 Million | -23.94 Million | -31.47 Million | -64.05 Million | -111.72 Million | -134.83 Million |
| Acquisitions | 1.78 Million | 3.23 Million | 7 Million | 1.52 | - | - |
| Investment purchases | -155 Million | - | -60 Million | -45.15 Million | -230 Million | - |
| Sales/Maturities of investments | 153.22 Million | - | 60.39 Million | 40.06 Million | 232.18 Million | - |
| Other Investing Activities | 11.25 Million | 2.35 Million | 1.6 Million | 883.67 Thousand | 909.51 Thousand | 2.63 Million |
| Financing Cash Flow | -1.87 Million | -38.44 Million | 42.49 Million | 29.7 Million | 44.53 Million | -32.53 Million |
| Debt repayment | -15.95 Million | -128.78 Million | -101.74 Million | -108.28 Million | -78.28 Million | -15 Million |
| Dividends payments | -5.57 Million | -8.69 Million | -7.89 Million | -4.8 Million | -32 Million | -16 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | -1.12 Million |
| Other Financing Activities | 19.65 Million | 99.02 Million | 152.12 Million | 149.62 Million | 156.24 Million | -16.53 Million |
| Accounts receivables | 60.68 Million | -5.02 Million | -10.33 Million | 54.11 Million | -52.19 Million | -54.62 Million |
| Accounts payables | -27.37 Million | 29.73 Million | 28.58 Million | 9.05 Million | -17.82 Million | 11.55 Million |
| Inventory | -28.84 Million | -15.89 Million | 6.51 Million | -12.86 Million | -7.35 Million | -20.15 Million |
| Other working capital | -346.97 Thousand | 7.57 Million | 4 Million | 14.55 Million | -17.16 Million | -54.74 Million |
| Cash at beginning of period | 70.6 Million | 113.27 Million | 57.79 Million | 96.17 Million | 206.78 Million | 368.2 Million |
| Cash at end of period | 85.1 Million | 70.6 Million | 113.27 Million | 57.79 Million | 96.17 Million | 206.78 Million |
| Capital Expenditure | -30.57 Million | -23.94 Million | -31.47 Million | -64.05 Million | -111.72 Million | -134.83 Million |
| Effect of forex changes on cash | 0.17 | 0.73 | - | - | - | - |
| Net cash flow / Change in cash | 14.5 Million | -42.67 Million | 55.47 Million | -38.37 Million | -110.6 Million | -161.41 Million |
| Free Cash Flow | 5.12 Million | -9.81 Million | 3.98 Million | -63.88 Million | -158.24 Million | -131.51 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.45 Million | 140.59 Thousand | 1.62 Million | 5.2 Million | 9.53 Million | 1.33 Million |
| Depreciation & Amortization | - | 8.32 Million | 8.32 Million | 33.13 Million | 33.13 Million | -16.41 Million |
| Deferred income taxes | - | - | - | - | 12.75 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -35.82 Million | - | 31.48 Million | 4.11 Million | 10.63 Million |
| Other non-cash items | 20.26 Million | -20.87 Million | -19.06 Million | -36.95 Million | -11.07 Million | 5.2 Million |
| Investing Cash Flow | -10.91 Million | -2.11 Million | 1.18 Million | 26.9 Million | -19.32 Million | -21.83 Million |
| Investments in PPE | -6.86 Million | -5.21 Million | -6.12 Million | -11.08 Million | -30.57 Million | -7.1 Million |
| Acquisitions | 5.95 Million | 1.1 Million | 7.11 Million | -28.02 Million | 1.78 Million | 5700.00 |
| Investment purchases | -33.81 Million | -1249.90 | -89.99 Million | -30 Million | -155 Million | -90 Million |
| Sales/Maturities of investments | 23.81 Million | 2.13 Million | 90.06 Million | 58.02 Million | 153.22 Million | 75.18 Million |
| Other Investing Activities | -10 Million | 1249.90 | 131.76 Thousand | 37.98 Million | 11.25 Million | 82.07 Thousand |
| Financing Cash Flow | 24.25 Million | 6.94 Million | -14.32 Million | 10.45 Million | -1.87 Million | -14.49 Million |
| Debt repayment | -28.31 Million | -14.52 Million | -10 Million | -14.72 Million | -15.95 Million | -8.17 Million |
| Dividends payments | - | -5.35 Million | -842.52 Thousand | -1.62 Million | -5.57 Million | -669.02 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 24.25 Million | -1.88 Million | -3.48 Million | -2.64 Million | 19.65 Million | -5.64 Million |
| Accounts receivables | - | -47.41 Million | - | 60.68 Million | 60.68 Million | -18.76 Million |
| Accounts payables | - | - | - | - | -27.37 Million | -4.51 Million |
| Inventory | - | 9.57 Million | - | -28.84 Million | -28.84 Million | 29.4 Million |
| Other working capital | - | 2.01 Million | - | -346.97 Thousand | -346.97 Thousand | 4.51 Million |
| Cash at beginning of period | 32.31 Million | 56.54 Million | 85.1 Million | 14.87 Million | 70.6 Million | 50.48 Million |
| Cash at end of period | 58.45 Million | 32.31 Million | 54.53 Million | 85.1 Million | 85.1 Million | 14.87 Million |
| Capital Expenditure | -6.86 Million | -5.21 Million | -6.12 Million | -11.08 Million | -30.57 Million | -7.1 Million |
| Effect of forex changes on cash | - | - | 0.28 | 2.00 | 0.17 | -52.67 Thousand |
| Net cash flow / Change in cash | 26.13 Million | -24.22 Million | -30.57 Million | 70.23 Million | 14.5 Million | -35.61 Million |
| Free Cash Flow | 7.93 Million | -34.27 Million | -23.56 Million | 21.78 Million | 5.12 Million | -6.34 Million |
4557
PNFPP
2778
2061
3141
HMVL